Premium
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
XORTX Therapeutics Inc is a clinical-stage biotechnology company. The company focused on developing drug therapies for orphan diseases like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes. XORTX Therapeutics Inc is a clinical-stage biotechnology company. The company focused on developing drug therapies for orphan diseases like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0052 | -0.587504236809 | 0.8851 | 1.1 | 0.8515 | 14494 | 1.00161367 | CS |
| 4 | -0.0301 | -3.30769230769 | 0.91 | 1.25 | 0.81 | 86850 | 0.98332269 | CS |
| 12 | -0.3201 | -26.675 | 1.2 | 1.79 | 0.81 | 141818 | 1.15269765 | CS |
| 26 | -1.0801 | -55.1071428571 | 1.96 | 2.51 | 0.81 | 92867 | 1.34764751 | CS |
| 52 | -3.9101 | -81.630480167 | 4.79 | 5.81 | 0.81 | 788533 | 2.59728044 | CS |
| 156 | -11.7201 | -93.0166666667 | 12.6 | 22.32 | 0.81 | 559882 | 5.43774024 | CS |
| 260 | -118.2801 | -99.2615810675 | 119.16 | 119.16 | 0.81 | 439542 | 9.34019709 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
